Biblio

Found 4 results
Filters: Keyword is Receptors, Estrogen  [Clear All Filters]
2022
Johansson A, Yu NY, Iftimi A, Tobin NP, Veer Lvan 't, Nordenskjöld B, Benz CC, Fornander T, Perez-Tenorio G, Stål O, et al. Clinical and molecular characteristics of estrogen receptor-positive ultralow risk breast cancer tumors identified by the 70-gene signature. Int J Cancer. 2022 ;150(12):2072-2082.
A Chien J, Kyalwazi B, Esserman LJ. Optimizing hormone therapy for breast cancer: Translating gains to the early-stage setting. Cell Rep Med. 2022 ;3(6):100664.
Wolf DM, Yau C, Wulfkuhle J, Brown-Swigart L, Gallagher RI, Lee PRong Evely, Zhu Z, Magbanua MJ, Sayaman R, O'Grady N, et al. Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies. Cancer Cell. 2022 ;40(6):609-623.e6.
Johansson A, Dar H, Veer LJ van 't, Tobin NP, Perez-Tenorio G, Nordenskjöld A, Johansson U, Hartman J, Skoog L, Yau C, et al. Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial. J Clin Oncol. 2022 ;40(35):4071-4082.